{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T14:24:32Z","timestamp":1773325472064,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2001,3,1]],"date-time":"2001-03-01T00:00:00Z","timestamp":983404800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gastroenterology"],"published-print":{"date-parts":[[2001,3]]},"DOI":"10.1053\/gast.2001.22556","type":"journal-article","created":{"date-parts":[[2007,2,21]],"date-time":"2007-02-21T12:18:36Z","timestamp":1172060316000},"page":"995-999","source":"Crossref","is-referenced-by-count":137,"title":["Anti\u2013tumor necrosis factor monoclonal antibody therapy for gastrointestinal Beh\u00e7et's disease: A case report"],"prefix":"10.1053","volume":"120","author":[{"given":"Philip V.","family":"Hassard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott W.","family":"Binder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viera","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric A.","family":"Vasiliauskas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/gast.2001.22556_bib1","first-page":"1078","article-title":"Criteria for diagnosis of Beh\u00e7et's disease. International Study Group for Beh\u00e7et's Disease","volume":"335","author":"Anonymous","year":"1990","journal-title":"Lancet"},{"key":"10.1053\/gast.2001.22556_bib2","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1056\/NEJM199910213411707","article-title":"Beh\u00e7et's disease","volume":"341","author":"Sakane","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1053\/gast.2001.22556_bib3","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0025-7125(16)31562-0","article-title":"Differential diagnosis of ulcerative colitis and Crohn's ileocolitis and other specific inflammatory disease of the bowel","volume":"64","author":"Tedesco","year":"1980","journal-title":"Med Clin North Am"},{"key":"10.1053\/gast.2001.22556_bib4","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/00005176-199910000-00021","article-title":"Intestinal Beh\u00e7et's disease: a case report and review of Japanese reports in children","volume":"29","author":"Tabata","year":"1999","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1053\/gast.2001.22556_bib5","first-page":"1544","article-title":"Overproduction of monocyte derived tumor necrosis factor alpha, interleukin (IL) 6, IL-8 and increased neutrophil superoxide generation in Beh\u00e7et's disease. A comparative study with familial Mediterranean fever and healthy subjects","volume":"20","author":"Mege","year":"1993","journal-title":"J Rheumatol"},{"key":"10.1053\/gast.2001.22556_bib6","first-page":"687","article-title":"Immunopathological aspects of Beh\u00e7et's disease (editorial)","volume":"13","author":"Emmi","year":"1995","journal-title":"Clin Exp Rheumatol"},{"key":"10.1053\/gast.2001.22556_bib7","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1056\/NEJM199710093371502","article-title":"A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease","volume":"337","author":"Targan","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1053\/gast.2001.22556_bib8","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0140-6736(97)80083-9","article-title":"Randomised controlled trial of CDP571 antibody to tumour necrosis factor\u2013alpha in Crohn's disease","volume":"349","author":"Stack","year":"1997","journal-title":"Lancet"},{"key":"10.1053\/gast.2001.22556_bib9","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/S0140-6736(94)90628-9","article-title":"Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis","volume":"344","author":"Elliott","year":"1994","journal-title":"Lancet"},{"key":"10.1053\/gast.2001.22556_bib10","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/S0140-6736(99)05246-0","article-title":"Infliximab (chimeric anti\u2013tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial","volume":"354","author":"Maini","year":"1999","journal-title":"Lancet"},{"key":"10.1053\/gast.2001.22556_bib11","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S0016-5085(99)70332-X","article-title":"Efficacy and safety of retreatment with anti\u2013tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease","volume":"117","author":"Rutgeerts","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1053\/gast.2001.22556_bib12","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0016-5085(76)80163-1","article-title":"Development of a Crohn's Disease Activity Index. National Cooperative Crohn's Disease Study","volume":"70","author":"Best","year":"1976","journal-title":"Gastroenterology"},{"key":"10.1053\/gast.2001.22556_bib13","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/S0016-5085(89)80080-0","article-title":"A new measure of health status for clinical trials in inflammatory bowel disease","volume":"96","author":"Guyatt","year":"1989","journal-title":"Gastroenterology"},{"key":"10.1053\/gast.2001.22556_bib14","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s003840050183","article-title":"Quality of life in Korean patients with inflammatory bowel diseases: ulcerative colitis, Crohn's disease and intestinal Beh\u00e7et's disease","volume":"14","author":"Kim","year":"1999","journal-title":"Int J Colorectal Dis"},{"key":"10.1053\/gast.2001.22556_bib15","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1006\/cyto.1995.0029","article-title":"Chimeric anti\u2013TNF-alpha monoclonal antibody cA2 binds recombinant transmembrane TNF-alpha and activates immune effector functions","volume":"7","author":"Scallon","year":"1995","journal-title":"Cytokine"},{"key":"10.1053\/gast.2001.22556_bib16","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/rheumatology\/33.2.115","article-title":"Validation of the International Study Group criteria for Beh\u00e7et's disease","volume":"33","author":"O'Neill","year":"1994","journal-title":"Br J Rheumatol"},{"key":"10.1053\/gast.2001.22556_bib17","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0049-0172(79)90004-0","article-title":"Beh\u00e7et disease (Beh\u00e7et syndrome)","volume":"8","author":"Shimizu","year":"1979","journal-title":"Semin Arthritis Rheum"},{"key":"10.1053\/gast.2001.22556_bib18","first-page":"CD001084","article-title":"Pharmacotherapy for Beh\u00e7et's syndrome","volume":"2","author":"Saenz","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1053\/gast.2001.22556_bib19","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1002\/art.1780391216","article-title":"The effect of prophylactic penicillin treatment on the course of arthritis episodes in patients with Beh\u00e7et's disease. A randomized clinical trial","volume":"39","author":"Calguneri","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1053\/gast.2001.22556_bib20","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1056\/NEJM199002013220501","article-title":"A controlled trial of azathioprine in Beh\u00e7et's syndrome","volume":"322","author":"Yazici","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1053\/gast.2001.22556_bib21","doi-asserted-by":"crossref","first-page":"891","DOI":"10.7326\/0003-4819-124-10-199605150-00005","article-title":"Successful treatment of Beh\u00e7et disease with pentoxifylline","volume":"124","author":"Yasui","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1053\/gast.2001.22556_bib22","doi-asserted-by":"crossref","first-page":"443","DOI":"10.7326\/0003-4819-128-6-199803150-00004","article-title":"Thalidomide in the treatment of the mucocutaneous lesions of the Beh\u00e7et syndrome. A randomized, double-blind, placebo-controlled trial","volume":"128","author":"Hamuryudan","year":"1998","journal-title":"Ann Inter Med"},{"key":"10.1053\/gast.2001.22556_bib23","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0171-2985(11)80356-6","article-title":"Inhibition of endogenous TNF formation by pentoxifylline","volume":"187","author":"Zabel","year":"1993","journal-title":"Immunobiology"},{"key":"10.1053\/gast.2001.22556_bib24","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1365-2249.1997.tb08310.x","article-title":"Thalidomide and derivatives: immunological investigations of tumour necrosis factor\u2013alpha (TNF-alpha) inhibition suggest drugs capable of selective gene regulation","volume":"110","author":"McHugh","year":"1997","journal-title":"Clin Exp Immunol"},{"key":"10.1053\/gast.2001.22556_bib25","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/00054725-199905000-00008","article-title":"Antitumor necrosis factor therapy for inflammatory bowel disease: a review of agents, pharmacology, clinical results, and safety","volume":"5","author":"Sandborn","year":"1999","journal-title":"Inflamm Bowel Dis"},{"key":"10.1053\/gast.2001.22556_bib26","first-page":"G3174","article-title":"Delayed hypersensitivity to infliximab (Remicade (R)) re-infusion after a 2\u20134 year interval without treatment","volume":"116","author":"Hanauer","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1053\/gast.2001.22556_bib27","article-title":"Monoclonal antibody therapy in inflammatory bowel disease.","volume":"Volume 2","author":"Vasiliauskas","year":"1999"},{"key":"10.1053\/gast.2001.22556_bib28","first-page":"A144","article-title":"Collaborative experience of open-label infliximab, in refractory pediatric Crohn's disease","volume":"525","author":"Vasiliauskas","year":"1999","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1053\/gast.2001.22556_bib29","first-page":"1428","article-title":"Production of TNF-alpha and IL-1 in active Beh\u00e7et's disease","volume":"17","author":"Hamzaoui","year":"1990","journal-title":"J Rheumatol"},{"key":"10.1053\/gast.2001.22556_bib30","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1002\/1529-0131(199909)42:9<1967::AID-ANR24>3.0.CO;2-Z","article-title":"Th1 polarization of the immune response in Beh\u00e7et's disease: a putative pathogenetic role of interleukin-12","volume":"42","author":"Frassanito","year":"1999","journal-title":"Arthritis Rheum"}],"container-title":["Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001650850183907X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001650850183907X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,20]],"date-time":"2020-04-20T05:16:09Z","timestamp":1587359769000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001650850183907X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,3]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2001,3]]}},"alternative-id":["S001650850183907X"],"URL":"https:\/\/doi.org\/10.1053\/gast.2001.22556","relation":{},"ISSN":["0016-5085"],"issn-type":[{"value":"0016-5085","type":"print"}],"subject":[],"published":{"date-parts":[[2001,3]]}}}